Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
220.35
+0.04 (0.02%)
At close: Dec 18, 2025, 4:00 PM EST
220.35
0.00 (0.00%)
After-hours: Dec 18, 2025, 7:07 PM EST
Cidara Therapeutics Market Cap
Cidara Therapeutics has a market cap or net worth of $6.93 billion as of December 18, 2025. Its market cap has increased by 5,140.29% in one year.
Market Cap
6.93B
Enterprise Value
6.51B
1-Year Change
5,140.29%
Ranking
Category
Stock Price
$220.35
Market Cap Chart
Since April 15, 2015, Cidara Therapeutics's market cap has increased from $203.10M to $6.93B, an increase of 3,310.96%. That is a compound annual growth rate of 39.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 6.93B | 3,557.02% |
| Dec 31, 2024 | 189.40M | 163.79% |
| Dec 29, 2023 | 71.80M | 32.47% |
| Dec 30, 2022 | 54.20M | -36.01% |
| Dec 31, 2021 | 84.70M | -3.64% |
| Dec 31, 2020 | 87.90M | -30.73% |
| Dec 31, 2019 | 126.90M | 94.63% |
| Dec 31, 2018 | 65.20M | -52.62% |
| Dec 29, 2017 | 137.60M | -20.65% |
| Dec 30, 2016 | 173.40M | -26.34% |
| Dec 31, 2015 | 235.40M | 15.90% |
| Apr 15, 2015 | 203.10M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.06B |
| Johnson & Johnson | 516.00B |
| AbbVie | 401.99B |
| UnitedHealth Group | 308.98B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 223.39B |